Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate–Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate–Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study

Published:2023-11 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Yu Evan Y.,Berry William R.,Gurney Howard,Retz Margitta,Conter Henry J.,Laguerre Brigitte,Fong Peter C.C.,Ferrario Cristiano,Todenhöfer Tilman,Gravis Gwenaelle,Piulats Josep M.,Emmenegger Urban,Shore Neal D.,Romano Emanuela,Mourey Loic,Li Xin Tong,Poehlein Christian H.,Schloss Charles,Appleman Leonard J.,de Bono Johann S.

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference38 articles.

1. Abiraterone in metastatic prostate cancer without previous chemotherapy;Ryan;N Engl J Med,2013

2. Enzalutamide in metastatic prostate cancer before chemotherapy;Beer;N Engl J Med,2014

3. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012

4. Olaparib for metastatic castration-resistant prostate cancer;de Bono;N Engl J Med,2020

5. Rucaparib in men with metastatic castration-resistant prostate cancer harboring a BRCA1 or BRCA2 gene alteration;Abida;J Clin Oncol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP